High Complexity Labs fully embraces its role as a member of the team managing the complex treatment of chronic or acute pain. About 50 million people suffer chronic pain and an additional 25 million suffer acute pain, which translates to $100 billion yearly in treating pain. Lost productivity is estimated to be $60 billion and the societal impacts are immeasurable. One of the many concerns in pain management is the identification of patients that have aberrant drug-related behavior or a potential for same.
The major drugs that are available for pain management have limitations and have a high potential for abuse or misuse. Clinical guidelines have been published to assist providers in managing the treatment of patients with chronic non-cancer pain.
At High Complexity Labs we work to improve physician awareness of patient conformance with drug therapy, identify and reduce narcotic diversion, minimize adverse drug reactions, and facilitate personalized patient care through innovative analytical services.
We are consistently expanding our toxicology testing lab menu in order to stay current with new medications and illicit drugs. Advanced Liquid Chromatography / Mass Spectrometry (LC/MS/MS) testing technology is set with the industry’s most precise toxicology detection levels, to ensure the highest sensitivity. Liquid chromatography – triple quadrupole mass spectrometry (LC/MS/MS) enables the quantification of metabolites in medications indicating patient’s compliance with prescriptions. The usage of LC/MS/MS allows for full advantage of chromatographic principles, thus allowing for increases in speed, resolution, and sensitivity. This high complexity testing is considered a “Gold Standard” with high accuracy and low cut-off points.